NIPC Law

Eli Lilly & Co.'s factory in Indianapolis in 1862 Author Eli Lilly & Co. Source Wikipedia Jane Lambert Patents Court (Mr Roger Wyand QC) Eli Lilly and Co. v Genentech, In c [2020] EWHC 261 (Pat) (14 Feb 2020) This was the trial of a preliminary issue and application for summary judgment in Eli Lilly and Co.'s claim for revocation of Genentech Inc.'s European patent  (UK) EP2784084  for Antagonist antibodies to il-17a/f heterologous polypeptides.  Genentech alleged that the patent was valid and that Eli Lilly had infringed it and counterclaimed for the usual remedies for patent infringement.  The action and counterclaim came on before Mr Roger Wyand QC sitting as a deputy judge of the High Court on 28 and 29 Jan 2020 and he delivered judgment in  Eli Lilly and Co. v Genentech, In c [2020] EWHC 261 on St. Valentine's day. The preliminary issue was whether certain matters were res judicata by reason of Mr Justice Arnold's decision in Eli Lill...

Colonel Eli Lilly, Source Wikipedia Eli Lilly Jane Lambert Patents Court (Mr Justice Arnold) Eli Lilly and Co. and others v Genentech Inc .  [2019] EWHC 387 (Pat) (1 March 2019) This was a claim for the revocation of Genentech Inc.'s European patent EP1641822 for heterologous polypeptides and therapeutic uses thereof  on grounds of want of novelty, obviousness and insufficiency and a declaration of non-infringement of the patent; Genentech counterclaimed for infringement alleging that Lilly's product Ixekizumab  marketed under the trade mark Taltz infringed its patent. The action and counterclaim came on before Mr Justice Arnold as he then was. The judge also had to decide whether Genentech was entitled to a supplemental protection certificate in relation to the patent. His lordship dealt with that issue in a separate judgment (see Eli Lilly And Company v Genentech, Inc No. 2 [2019] EWHC 388 (Pat) (1 March 2019) which I discussed in Supplem...